Biosimilars guidance updated for hospitals


The Council of Therapeutic Advisory Groups (CATAG) has highlighted the importance of accurate and consistent communication about biosimilars across all  areas of patient care. In an update of their Guiding principles for the governance of biological and biosimilar medicines in Australian hospitals, CATAG recommended that biologics and biosimilars are always described by both their active ...


Already a member? Login to keep reading


OR
© 2017 the limbic